Skip to main content
. Author manuscript; available in PMC: 2021 Aug 27.
Published in final edited form as: JAMA Neurol. 2021 May 1;78(5):568–577. doi: 10.1001/jamaneurol.2021.0178

Figure 2. Longitudinal Change in Alzheimer Disease Magnetic Resonance Imaging Biomarkers by Age and Treatment Group.

Figure 2.

Bold lines represent age-specific change for each measurement estimated from a treatment group specific linear mixed model, with associated 95%CIs. Gray lines represent individual participant trajectories. ROIs indicate regions of interest; SPARE-AD, spatial pattern for recognition of Alzheimer disease.